224 related articles for article (PubMed ID: 23657302)
41. Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis.
Ingiliz P; Valantin MA; Preziosi P; Finzi L; Pais R; Fedchuk L; Dominguez S; Katlama C; Poynard T; Benhamou Y
J Hepatol; 2012 Jan; 56(1):49-54. PubMed ID: 21781946
[TBL] [Abstract][Full Text] [Related]
42. Gender differences in liver fibrosis and hepatitis C virus-related parameters in patients coinfected with human immunodeficiency virus.
Collazos J; Cartón JA; Asensi V
Curr HIV Res; 2011 Jul; 9(5):339-45. PubMed ID: 21827383
[TBL] [Abstract][Full Text] [Related]
43. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
[TBL] [Abstract][Full Text] [Related]
44. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.
Bierhoff E; Fischer HP; Willsch E; Rockstroh J; Spengler U; Brackmann HH; Oldenburg J
Virchows Arch; 1997 Apr; 430(4):271-7. PubMed ID: 9134037
[TBL] [Abstract][Full Text] [Related]
45. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count].
Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M
Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391
[TBL] [Abstract][Full Text] [Related]
46. HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.
Cooper C; Rollet-Kurhajec KC; Young J; Vasquez C; Tyndall M; Gill J; Pick N; Walmsley S; Klein MB;
HIV Med; 2015 Jan; 16(1):24-31. PubMed ID: 24837567
[TBL] [Abstract][Full Text] [Related]
47. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
[TBL] [Abstract][Full Text] [Related]
48. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
[TBL] [Abstract][Full Text] [Related]
49. Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: prospective analysis of 435 liver biopsy pairs.
Konerman MA; Mehta SH; Sutcliffe CG; Vu T; Higgins Y; Torbenson MS; Moore RD; Thomas DL; Sulkowski MS
Hepatology; 2014 Mar; 59(3):767-75. PubMed ID: 24436062
[TBL] [Abstract][Full Text] [Related]
50. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
51. Revisiting liver disease progression in HIV/HCV-coinfected patients: the influence of vitamin D, insulin resistance, immune status, IL28B and PNPLA3.
Mandorfer M; Payer BA; Schwabl P; Steiner S; Ferlitsch A; Aichelburg MC; Stättermayer AF; Ferenci P; Obermayer-Pietsch B; Grabmeier-Pfistershammer K; Trauner M; Peck-Radosavljevic M; Reiberger T
Liver Int; 2015 Mar; 35(3):876-85. PubMed ID: 24905495
[TBL] [Abstract][Full Text] [Related]
52. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin.
Bräu N
Semin Liver Dis; 2005 Feb; 25(1):33-51. PubMed ID: 15731996
[TBL] [Abstract][Full Text] [Related]
53. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity.
Feuth T; Van Baarle D; Hoepelman AI; Van Erpecum KJ; Siersema PD; Arends JE
Apoptosis; 2014 Jul; 19(7):1128-35. PubMed ID: 24752774
[TBL] [Abstract][Full Text] [Related]
54. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
Macías J; Mira JA; López-Cortés LF; Santos I; Girón-González JA; González-Serrano M; Merino D; Hernández-Quero J; Rivero A; Merchante N; Trastoy M; Carrillo-Gómez R; Arizcorreta-Yarza A; Gómez-Mateos J; Pineda JA
Antivir Ther; 2006; 11(7):839-46. PubMed ID: 17302246
[TBL] [Abstract][Full Text] [Related]
55. Update on chronic hepatitis C in HIV/HCV-coinfected patients: viral interactions and therapy.
Bräu N
AIDS; 2003 Nov; 17(16):2279-90. PubMed ID: 14571179
[TBL] [Abstract][Full Text] [Related]
56. Progression of liver fibrosis in patients coinfected with hepatitis C virus and human immunodeficiency virus undergoing antiretroviral therapy.
Pineda JA; Macías J
J Antimicrob Chemother; 2005 Apr; 55(4):417-9. PubMed ID: 15731202
[TBL] [Abstract][Full Text] [Related]
57. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.
Puoti M; Bonacini M; Spinetti A; Putzolu V; Govindarajan S; Zaltron S; Favret M; Callea F; Gargiulo F; Donato F; Carosi G;
J Infect Dis; 2001 Jan; 183(1):134-7. PubMed ID: 11087200
[TBL] [Abstract][Full Text] [Related]
58. The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients.
Núñez-Torres R; Macías J; Mancebo M; Frías M; Dolci G; Téllez F; Merino D; Merchante N; Gómez-Mateos J; Guaraldi G; Rivero-Juárez A; Pineda JA; Real LM;
PLoS One; 2016; 11(12):e0168265. PubMed ID: 27973562
[TBL] [Abstract][Full Text] [Related]
59. Clinicoimmunological progression and response to treatment of long-term nonprogressor HIV-hepatitis C virus-coinfected patients.
Castro P; Laguno M; Nomdedeu M; López A; Plana M; Fumero E; Gallart T; Mallolas J; Gatell JM; García F
AIDS Res Hum Retroviruses; 2007 Jul; 23(7):863-7. PubMed ID: 17678468
[TBL] [Abstract][Full Text] [Related]
60. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
Bani-Sadr F; Carrat F; Bedossa P; Piroth L; Cacoub P; Perronne C; Degott C; Pol S;
AIDS; 2006 Feb; 20(4):525-31. PubMed ID: 16470116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
